Anyone else think Monil Shah renumeration is a bit rich..?
He gets $190K bonus for signing a pre clinical partnership for OnCARlytic's. That was it to meet his KPI.
Current T cell therapy can only go after blood cancers. I cant see the difficultly or "work" required to get a partner for mouse models on solid tumours. And correct me if I am wrong, but aren't we covering our own costs in this partnership?
Given his $595K static salary. In my opinion if he hasn't generated any revenue for the company he should not be inline to receive a bonus.
He's also paid in a fixed USD amount. If the Ozzie tumbles he'll end up getting more then Leslie at this rate.
Hate to think what his bonus would be if he actually signs a commercial deal.
Ann: Annual Report to shareholders, page-30
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |